Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Jussi P, Pärkkä"'
Autor:
Roosa Lankinen, Markus Hakamäki, Kaj Metsärinne, Niina Koivuviita, Jussi P. Pärkkä, Maria Saarenhovi, Tapio Hellman, Mikko J. Järvisalo
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-8 (2021)
Abstract Background Cardiac biomarkers Troponin T (TnT) and N-terminal pro-B-type natriuretic peptide (proBNP) and abdominal aortic calcification score (AAC) are associated with cardiovascular events and mortality in patients with chronic kidney dise
Externí odkaz:
https://doaj.org/article/3072d7a5dde74a4e931bc1ebd0b53758
Autor:
Niina Koivuviita, Tapio Hellman, Mikko J. Järvisalo, Kaj Metsärinne, Maria Saarenhovi, Jussi P. Pärkkä, Markus Hakamäki, Roosa Lankinen
Publikováno v:
Blood Purification. 50:347-354
Introduction: Patients with CKD have an impaired health-related quality of life (QoL). Most studies have been conducted on dialysis patients, and less is known about QoL and its determinants in predialysis patients. We studied the association between
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d16f98c3570a92721c44da717033136c
https://doi.org/10.1159/000510984
https://doi.org/10.1159/000510984
Autor:
Tapio Hellman, Niina Koivuviita, Petri Kallio, Markus Hakamäki, Roosa Lankinen, Jussi P. Pärkkä, Mikko J. Järvisalo, Kaj Metsärinne
Publikováno v:
Kidney & Blood Pressure Research, Pp 1-9 (2021)
Introduction: Chronic kidney disease (CKD) is associated with impaired maximal exercise capacity (MEC). However, data are scarce on the development of MEC in CKD stage 4–5 patients transitioning to renal replacement therapy (RRT). Methods: We explo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53ef765bba9b15f77b9372093d2fd650
https://pubmed.ncbi.nlm.nih.gov/34823249
https://pubmed.ncbi.nlm.nih.gov/34823249
Autor:
Markus Hakamäki, Mikko J. Järvisalo, Roosa Lankinen, Niina Koivuviita, Jussi P. Pärkkä, Andrea Kozak-Barany, Tapio Hellman, Kaj Metsärinne
Publikováno v:
Nephron. 146(5)
Introduction: Chronic kidney disease (CKD) has a profound effect on patients’ health-related quality of life (QoL). Longitudinal studies on QoL in CKD are scarce and have explored selected patients on renal replacement therapy (RRT). We studied the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acad05ae17f65d3e1eadb94be1c2aaf6
https://pubmed.ncbi.nlm.nih.gov/35139517
https://pubmed.ncbi.nlm.nih.gov/35139517
Autor:
Tapio Hellman, Niina Koivuviita, Markus Hakamäki, Mikko J. Järvisalo, Jussi P. Pärkkä, Maria Saarenhovi, Kaj Metsärinne, Roosa Lankinen
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-8 (2021)
BMC Nephrology
BMC Nephrology
Background Cardiac biomarkers Troponin T (TnT) and N-terminal pro-B-type natriuretic peptide (proBNP) and abdominal aortic calcification score (AAC) are associated with cardiovascular events and mortality in patients with chronic kidney disease (CKD)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b414506d744fa637d7a0c6adae6cb0b6
https://doi.org/10.1186/s12882-021-02251-y
https://doi.org/10.1186/s12882-021-02251-y
Autor:
Niina Koivuviita, Kaj Metsärinne, Markus Hakamäki, Tapio Hellman, Mikko J. Järvisalo, Jussi P. Pärkkä, Maria Saarenhovi, Roosa Lankinen
Background Cardiac biomarkers Troponin T (TnT) and N-terminal pro-B-type natriuretic peptide (proBNP) and abdominal aortic calcification score (AAC) are associated with cardiovascular events and mortality in patients with chronic kidney disease (CKD)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5217705a91a9f5eda2ea05d1949110ed
https://doi.org/10.21203/rs.3.rs-74844/v1
https://doi.org/10.21203/rs.3.rs-74844/v1
Autor:
Mikko J. Järvisalo, Kaj Metsärinne, Jussi P. Pärkkä, K.E. Juhani Airaksinen, Petri Kallio, Niina Koivuviita, Roosa Lankinen, Markus Hakamäki, Tapio Hellman, Tuomas Kiviniemi
Publikováno v:
Nephron. 145(1)
Introduction: Atrial fibrillation (AF) and CKD are commonly coexisting conditions. However, data on epidemiology of AF in patients with CKD stage 4–5 is scarce. Methods: We prospectively enrolled 210 consecutive non-dialysis patients with CKD stage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6dc89a694db3c08c2cf4722daa109cf
https://pubmed.ncbi.nlm.nih.gov/33264772
https://pubmed.ncbi.nlm.nih.gov/33264772
Autor:
Tapio Hellman, Juhani Airaksinen, Mikko J. Järvisalo, Kaj Metsärinne, Roosa Lankinen, Niina Koivuviita, Jussi P. Pärkkä, Markus Hakamäki, Tuomas Kiviniemi, Petri Kallio
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Atrial fibrillation (AF) and chronic kidney disease (CKD) are common and often co-existing conditions. However, little is known on the prevalence and incidence of AF in patients with CKD stage 4-5. Method We prospectively recruite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10e3bebfdb2d483ef2b10ff767869902
https://doi.org/10.1093/ndt/gfaa142.p0252
https://doi.org/10.1093/ndt/gfaa142.p0252
Autor:
Roosa Lankinen, Mikko J. Järvisalo, Kaj Metsärinne, Olli T. Raitakari, Jussi P. Pärkkä, Markus Hakamäki, Noora Kartiosuo, Tapio Hellman
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Patients with chronic kidney disease (CKD) stage 4-5 have an increased risk of cardiovascular morbidity and mortality. Method We recruited 174 consecutive patients with CKD stage 4-5 between 2013 and 2017 into a prospective follow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e602ffb3a6785f12ec3068d750eb5dc
https://doi.org/10.1093/ndt/gfaa142.p0747
https://doi.org/10.1093/ndt/gfaa142.p0747
Autor:
Noora Kartiosuo, Kaj Metsärinne, Markus Hakamäki, Tapio Hellman, Mikko J. Järvisalo, Roosa Lankinen, Niina Koivuviita, Jussi P. Pärkkä, Olli T. Raitakari
Publikováno v:
American journal of nephrology. 51(9)
Background: Patients with advanced chronic kidney disease (CKD stage 4-5) have an increased risk of death. To study the determinants of all-cause mortality, we recruited 210 consecutive CKD stage 4-5 patients not on dialysis to the prospective Chroni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b82953fd44305aea49fcb90c6c43ddca
https://pubmed.ncbi.nlm.nih.gov/32777781
https://pubmed.ncbi.nlm.nih.gov/32777781